Literature DB >> 15188364

Chromatin breakdown during necrosis by serum Dnase1 and the plasminogen system.

Markus Napirei1, Swantje Wulf, Hans Georg Mannherz.   

Abstract

OBJECTIVE: Dnase1-deficient mice with the 129 x C57BL/6 genetic background develop symptoms of systemic lupus erythematosus, such as high titers of antinuclear autoantibodies directed against nucleosomes. In this study we analyzed a potential molecular pathomechanism leading to this autoimmunity, by exploring the influence of extracellular Dnase1 present in serum on the breakdown of chromatin in necrotic cells in vitro.
METHODS: Human breast adenocarcinoma cells (MCF-7) and other cell lines were subjected to necrosis induced by hydrogen peroxide, streptolysin O, or freeze-thawing. Subsequently, the influence of sera from Dnase1-deficient and wild-type mice as well as the influence of purified enzymes present in the culture medium on the process of necrotic chromatin breakdown was investigated.
RESULTS: Necrotic chromatin breakdown resembled apoptotic DNA laddering and was catalyzed by serum Dnase1 in conjunction with plasmin. During necrosis, Dnase1 and plasminogen penetrated the cell and accumulated in the cytoplasm and nucleus. Plasminogen bound to the cytoskeleton and nuclear structures, was activated to plasmin by either tissue-type or urokinase-type plasminogen activator, and degraded histone H1, thereby facilitating internucleosomal DNA cleavage by Dnase1.
CONCLUSION: Our results suggest that serum Dnase1 in cooperation with the plasminogen system guarantees a fast and effective breakdown of chromatin during necrosis by the combined cleavage of DNA as well as of DNA binding proteins. The failure of such a clearance mechanism might lead to antinuclear autoimmunity similar to that observed in the Dnase1-deficient mouse.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188364     DOI: 10.1002/art.20267

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

Review 1.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

2.  VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice.

Authors:  Alexander S Savchenko; Julian I Borissoff; Kimberly Martinod; Simon F De Meyer; Maureen Gallant; Luise Erpenbeck; Alexander Brill; Yanming Wang; Denisa D Wagner
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

3.  Extracellular chromatin is an important mediator of ischemic stroke in mice.

Authors:  Simon F De Meyer; Georgette L Suidan; Tobias A Fuchs; Marc Monestier; Denisa D Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

4.  DNA degradation and its defects.

Authors:  Kohki Kawane; Kou Motani; Shigekazu Nagata
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-06-02       Impact factor: 10.005

5.  Controlling DNA-nanoparticle serum interactions.

Authors:  Kyryl Zagorovsky; Leo Y T Chou; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

6.  Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3).

Authors:  Markus Napirei; Swantje Wulf; Dirk Eulitz; Hans Georg Mannherz; Thomas Kloeckl
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

7.  Intra- and Extracellular Degradation of Neutrophil Extracellular Traps by Macrophages and Dendritic Cells.

Authors:  Beatrice Lazzaretto; Bengt Fadeel
Journal:  J Immunol       Date:  2019-09-13       Impact factor: 5.422

8.  DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.

Authors:  Johanna Tuomela; Jouko Sandholm; Mika Kaakinen; Ankita Patel; Joonas H Kauppila; Joanna Ilvesaro; Dongquan Chen; Kevin W Harris; David Graves; Katri S Selander
Journal:  Breast Cancer Res Treat       Date:  2013-11-10       Impact factor: 4.872

9.  DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Authors:  Fernando Martinez-Valle; Eva Balada; Josep Ordi-Ros; Segundo Bujan-Rivas; Agustin Sellas-Fernandez; Miquel Vilardell-Tarres
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

10.  Comparison of apoptosis detection markers combined with macrophage immunostaining to study phagocytosis of apoptotic cells in situ.

Authors:  Dorien M Schrijvers; Guido R Y De Meyer; Mark M Kockx; Arnold G Herman; Wim Martinet
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.